nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—PPARG—systemic lupus erythematosus	0.273	0.703	CbGaD
Mesalazine—MPO—Dapsone—systemic lupus erythematosus	0.129	0.427	CbGbCtD
Mesalazine—PTGS2—systemic lupus erythematosus	0.115	0.297	CbGaD
Mesalazine—PTGS2—Dapsone—systemic lupus erythematosus	0.0446	0.147	CbGbCtD
Mesalazine—PTGS2—Triamcinolone—systemic lupus erythematosus	0.0387	0.128	CbGbCtD
Mesalazine—PTGS1—Dapsone—systemic lupus erythematosus	0.0377	0.124	CbGbCtD
Mesalazine—PTGS2—Betamethasone—systemic lupus erythematosus	0.0332	0.11	CbGbCtD
Mesalazine—PTGS2—Dexamethasone—systemic lupus erythematosus	0.0193	0.0638	CbGbCtD
Mesalazine—MPO—endothelium—systemic lupus erythematosus	0.00187	0.0438	CbGeAlD
Mesalazine—CHUK—connective tissue—systemic lupus erythematosus	0.00185	0.0435	CbGeAlD
Mesalazine—CHUK—skin of body—systemic lupus erythematosus	0.00167	0.0392	CbGeAlD
Mesalazine—MPO—blood plasma—systemic lupus erythematosus	0.00166	0.0389	CbGeAlD
Mesalazine—PPARG—endothelium—systemic lupus erythematosus	0.00166	0.0389	CbGeAlD
Mesalazine—PPARG—blood plasma—systemic lupus erythematosus	0.00147	0.0345	CbGeAlD
Mesalazine—CHUK—lymphoid tissue—systemic lupus erythematosus	0.00135	0.0318	CbGeAlD
Mesalazine—IKBKB—connective tissue—systemic lupus erythematosus	0.00126	0.0295	CbGeAlD
Mesalazine—IKBKB—skin of body—systemic lupus erythematosus	0.00114	0.0267	CbGeAlD
Mesalazine—Olsalazine—IFNG—systemic lupus erythematosus	0.00113	0.371	CrCbGaD
Mesalazine—CHUK—lung—systemic lupus erythematosus	0.00112	0.0262	CbGeAlD
Mesalazine—IKBKB—cortex of kidney—systemic lupus erythematosus	0.00104	0.0245	CbGeAlD
Mesalazine—ALOX5—connective tissue—systemic lupus erythematosus	0.00104	0.0245	CbGeAlD
Mesalazine—IKBKB—lymphoid tissue—systemic lupus erythematosus	0.00092	0.0216	CbGeAlD
Mesalazine—PTGS1—endothelium—systemic lupus erythematosus	0.000886	0.0208	CbGeAlD
Mesalazine—MPO—connective tissue—systemic lupus erythematosus	0.000883	0.0207	CbGeAlD
Mesalazine—IKBKB—tendon—systemic lupus erythematosus	0.000865	0.0203	CbGeAlD
Mesalazine—PTGS2—endothelium—systemic lupus erythematosus	0.000846	0.0199	CbGeAlD
Mesalazine—MPO—skin of body—systemic lupus erythematosus	0.000797	0.0187	CbGeAlD
Mesalazine—PTGS1—blood plasma—systemic lupus erythematosus	0.000787	0.0185	CbGeAlD
Mesalazine—PPARG—connective tissue—systemic lupus erythematosus	0.000783	0.0184	CbGeAlD
Mesalazine—ALOX5—lymphoid tissue—systemic lupus erythematosus	0.000763	0.0179	CbGeAlD
Mesalazine—IKBKB—lung—systemic lupus erythematosus	0.000759	0.0178	CbGeAlD
Mesalazine—PTGS2—blood plasma—systemic lupus erythematosus	0.000752	0.0176	CbGeAlD
Mesalazine—MPO—kidney—systemic lupus erythematosus	0.000751	0.0176	CbGeAlD
Mesalazine—PPARG—skin of body—systemic lupus erythematosus	0.000707	0.0166	CbGeAlD
Mesalazine—IKBKB—nervous system—systemic lupus erythematosus	0.000703	0.0165	CbGeAlD
Mesalazine—ALOX5—bone marrow—systemic lupus erythematosus	0.000695	0.0163	CbGeAlD
Mesalazine—IKBKB—central nervous system—systemic lupus erythematosus	0.000677	0.0159	CbGeAlD
Mesalazine—PPARG—kidney—systemic lupus erythematosus	0.000667	0.0156	CbGeAlD
Mesalazine—MPO—lymphoid tissue—systemic lupus erythematosus	0.000645	0.0151	CbGeAlD
Mesalazine—ALOX5—lung—systemic lupus erythematosus	0.000629	0.0148	CbGeAlD
Mesalazine—MPO—bone marrow—systemic lupus erythematosus	0.000588	0.0138	CbGeAlD
Mesalazine—ALOX5—nervous system—systemic lupus erythematosus	0.000583	0.0137	CbGeAlD
Mesalazine—PPARG—lymphoid tissue—systemic lupus erythematosus	0.000573	0.0134	CbGeAlD
Mesalazine—ALOX5—central nervous system—systemic lupus erythematosus	0.000561	0.0132	CbGeAlD
Mesalazine—PPARG—tendon—systemic lupus erythematosus	0.000538	0.0126	CbGeAlD
Mesalazine—MPO—lung—systemic lupus erythematosus	0.000532	0.0125	CbGeAlD
Mesalazine—Olsalazine—PPARG—systemic lupus erythematosus	0.000531	0.175	CrCbGaD
Mesalazine—PPARG—bone marrow—systemic lupus erythematosus	0.000522	0.0122	CbGeAlD
Mesalazine—MPO—nervous system—systemic lupus erythematosus	0.000493	0.0116	CbGeAlD
Mesalazine—MPO—central nervous system—systemic lupus erythematosus	0.000475	0.0111	CbGeAlD
Mesalazine—PPARG—lung—systemic lupus erythematosus	0.000472	0.0111	CbGeAlD
Mesalazine—PPARG—nervous system—systemic lupus erythematosus	0.000438	0.0103	CbGeAlD
Mesalazine—PPARG—central nervous system—systemic lupus erythematosus	0.000421	0.00989	CbGeAlD
Mesalazine—PTGS1—connective tissue—systemic lupus erythematosus	0.000419	0.00983	CbGeAlD
Mesalazine—PTGS2—connective tissue—systemic lupus erythematosus	0.0004	0.00939	CbGeAlD
Mesalazine—PTGS1—skin of body—systemic lupus erythematosus	0.000378	0.00887	CbGeAlD
Mesalazine—PTGS2—skin of body—systemic lupus erythematosus	0.000361	0.00848	CbGeAlD
Mesalazine—PTGS2—Fluocinonide—Methylprednisolone—systemic lupus erythematosus	0.000359	0.159	CbGdCrCtD
Mesalazine—PTGS1—kidney—systemic lupus erythematosus	0.000356	0.00837	CbGeAlD
Mesalazine—PTGS2—Fluocinonide—Betamethasone—systemic lupus erythematosus	0.000353	0.156	CbGdCrCtD
Mesalazine—PTGS2—Fluocinonide—Dexamethasone—systemic lupus erythematosus	0.000353	0.156	CbGdCrCtD
Mesalazine—PTGS2—Fluocinonide—Triamcinolone—systemic lupus erythematosus	0.000345	0.153	CbGdCrCtD
Mesalazine—PTGS2—kidney—systemic lupus erythematosus	0.000341	0.008	CbGeAlD
Mesalazine—Salicylate-sodium—PTGS2—systemic lupus erythematosus	0.000327	0.108	CrCbGaD
Mesalazine—PTGS2—lymphoid tissue—systemic lupus erythematosus	0.000293	0.00687	CbGeAlD
Mesalazine—PTGS1—tendon—systemic lupus erythematosus	0.000288	0.00675	CbGeAlD
Mesalazine—PTGS2—tendon—systemic lupus erythematosus	0.000275	0.00646	CbGeAlD
Mesalazine—PTGS2—bone marrow—systemic lupus erythematosus	0.000266	0.00625	CbGeAlD
Mesalazine—PTGS1—lung—systemic lupus erythematosus	0.000253	0.00593	CbGeAlD
Mesalazine—PTGS2—lung—systemic lupus erythematosus	0.000241	0.00567	CbGeAlD
Mesalazine—PTGS1—nervous system—systemic lupus erythematosus	0.000234	0.00549	CbGeAlD
Mesalazine—PTGS1—central nervous system—systemic lupus erythematosus	0.000225	0.00529	CbGeAlD
Mesalazine—Olsalazine—PTGS2—systemic lupus erythematosus	0.000224	0.0737	CrCbGaD
Mesalazine—PTGS2—nervous system—systemic lupus erythematosus	0.000224	0.00525	CbGeAlD
Mesalazine—PTGS2—Fluticasone Propionate—Methylprednisolone—systemic lupus erythematosus	0.000216	0.0957	CbGdCrCtD
Mesalazine—PTGS2—central nervous system—systemic lupus erythematosus	0.000215	0.00505	CbGeAlD
Mesalazine—PTGS2—Fluticasone Propionate—Dexamethasone—systemic lupus erythematosus	0.000213	0.0942	CbGdCrCtD
Mesalazine—PTGS2—Fluticasone Propionate—Betamethasone—systemic lupus erythematosus	0.000213	0.0942	CbGdCrCtD
Mesalazine—Diflunisal—PTGS2—systemic lupus erythematosus	0.000211	0.0693	CrCbGaD
Mesalazine—Aminosalicylic Acid—PTGS2—systemic lupus erythematosus	0.000211	0.0693	CrCbGaD
Mesalazine—PTGS2—Fluticasone Propionate—Triamcinolone—systemic lupus erythematosus	0.000208	0.0921	CbGdCrCtD
Mesalazine—Diflunisal—ALB—systemic lupus erythematosus	0.000188	0.0618	CrCbGaD
Mesalazine—Salicylic acid—PTGS2—systemic lupus erythematosus	0.000117	0.0386	CrCbGaD
Mesalazine—Salicylic acid—ALB—systemic lupus erythematosus	0.000104	0.0344	CrCbGaD
Mesalazine—Urethral disorder—Methotrexate—systemic lupus erythematosus	4.12e-05	0.000296	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	4.12e-05	0.000296	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	4.11e-05	0.000296	CcSEcCtD
Mesalazine—Pain—Hydrocortisone—systemic lupus erythematosus	4.1e-05	0.000295	CcSEcCtD
Mesalazine—Oedema—Dexamethasone—systemic lupus erythematosus	4.1e-05	0.000295	CcSEcCtD
Mesalazine—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	4.1e-05	0.000295	CcSEcCtD
Mesalazine—Oedema—Betamethasone—systemic lupus erythematosus	4.1e-05	0.000295	CcSEcCtD
Mesalazine—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	4.1e-05	0.000295	CcSEcCtD
Mesalazine—Insomnia—Triamcinolone—systemic lupus erythematosus	4.09e-05	0.000294	CcSEcCtD
Mesalazine—Insomnia—Methylprednisolone—systemic lupus erythematosus	4.08e-05	0.000293	CcSEcCtD
Mesalazine—Infection—Dexamethasone—systemic lupus erythematosus	4.07e-05	0.000293	CcSEcCtD
Mesalazine—Infection—Betamethasone—systemic lupus erythematosus	4.07e-05	0.000293	CcSEcCtD
Mesalazine—Ill-defined disorder—Prednisone—systemic lupus erythematosus	4.06e-05	0.000292	CcSEcCtD
Mesalazine—Paraesthesia—Triamcinolone—systemic lupus erythematosus	4.06e-05	0.000292	CcSEcCtD
Mesalazine—Feeling abnormal—Prednisolone—systemic lupus erythematosus	4.05e-05	0.000291	CcSEcCtD
Mesalazine—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	4.05e-05	0.000291	CcSEcCtD
Mesalazine—Anaemia—Prednisone—systemic lupus erythematosus	4.04e-05	0.000291	CcSEcCtD
Mesalazine—Shock—Betamethasone—systemic lupus erythematosus	4.03e-05	0.00029	CcSEcCtD
Mesalazine—Shock—Dexamethasone—systemic lupus erythematosus	4.03e-05	0.00029	CcSEcCtD
Mesalazine—Dyspnoea—Triamcinolone—systemic lupus erythematosus	4.03e-05	0.00029	CcSEcCtD
Mesalazine—Nervous system disorder—Betamethasone—systemic lupus erythematosus	4.02e-05	0.000289	CcSEcCtD
Mesalazine—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	4.02e-05	0.000289	CcSEcCtD
Mesalazine—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	4.01e-05	0.000289	CcSEcCtD
Mesalazine—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	4.01e-05	0.000289	CcSEcCtD
Mesalazine—Tachycardia—Dexamethasone—systemic lupus erythematosus	4e-05	0.000288	CcSEcCtD
Mesalazine—Tachycardia—Betamethasone—systemic lupus erythematosus	4e-05	0.000288	CcSEcCtD
Mesalazine—Angioedema—Prednisone—systemic lupus erythematosus	4e-05	0.000288	CcSEcCtD
Mesalazine—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	3.98e-05	0.000286	CcSEcCtD
Mesalazine—Dyspepsia—Triamcinolone—systemic lupus erythematosus	3.98e-05	0.000286	CcSEcCtD
Mesalazine—Erythema multiforme—Methotrexate—systemic lupus erythematosus	3.97e-05	0.000286	CcSEcCtD
Mesalazine—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	3.97e-05	0.000286	CcSEcCtD
Mesalazine—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	3.96e-05	0.000285	CcSEcCtD
Mesalazine—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	3.96e-05	0.000285	CcSEcCtD
Mesalazine—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	3.95e-05	0.000285	CcSEcCtD
Mesalazine—Malaise—Prednisone—systemic lupus erythematosus	3.95e-05	0.000284	CcSEcCtD
Mesalazine—Vertigo—Prednisone—systemic lupus erythematosus	3.93e-05	0.000283	CcSEcCtD
Mesalazine—Eye disorder—Methotrexate—systemic lupus erythematosus	3.93e-05	0.000283	CcSEcCtD
Mesalazine—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	3.92e-05	0.000282	CcSEcCtD
Mesalazine—Syncope—Prednisone—systemic lupus erythematosus	3.92e-05	0.000282	CcSEcCtD
Mesalazine—Tinnitus—Methotrexate—systemic lupus erythematosus	3.92e-05	0.000282	CcSEcCtD
Mesalazine—Anorexia—Betamethasone—systemic lupus erythematosus	3.91e-05	0.000281	CcSEcCtD
Mesalazine—Anorexia—Dexamethasone—systemic lupus erythematosus	3.91e-05	0.000281	CcSEcCtD
Mesalazine—Urticaria—Prednisolone—systemic lupus erythematosus	3.9e-05	0.000281	CcSEcCtD
Mesalazine—Cardiac disorder—Methotrexate—systemic lupus erythematosus	3.9e-05	0.000281	CcSEcCtD
Mesalazine—Fatigue—Triamcinolone—systemic lupus erythematosus	3.9e-05	0.00028	CcSEcCtD
Mesalazine—Fatigue—Methylprednisolone—systemic lupus erythematosus	3.89e-05	0.00028	CcSEcCtD
Mesalazine—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	3.88e-05	0.000279	CcSEcCtD
Mesalazine—Asthenia—Cyclosporine—systemic lupus erythematosus	3.87e-05	0.000279	CcSEcCtD
Mesalazine—Pain—Triamcinolone—systemic lupus erythematosus	3.86e-05	0.000278	CcSEcCtD
Mesalazine—Loss of consciousness—Prednisone—systemic lupus erythematosus	3.85e-05	0.000277	CcSEcCtD
Mesalazine—Hypotension—Betamethasone—systemic lupus erythematosus	3.83e-05	0.000276	CcSEcCtD
Mesalazine—Hypotension—Dexamethasone—systemic lupus erythematosus	3.83e-05	0.000276	CcSEcCtD
Mesalazine—Pruritus—Cyclosporine—systemic lupus erythematosus	3.82e-05	0.000275	CcSEcCtD
Mesalazine—Urticaria—Hydrocortisone—systemic lupus erythematosus	3.81e-05	0.000274	CcSEcCtD
Mesalazine—Angiopathy—Methotrexate—systemic lupus erythematosus	3.81e-05	0.000274	CcSEcCtD
Mesalazine—Immune system disorder—Methotrexate—systemic lupus erythematosus	3.79e-05	0.000273	CcSEcCtD
Mesalazine—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	3.79e-05	0.000273	CcSEcCtD
Mesalazine—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	3.79e-05	0.000273	CcSEcCtD
Mesalazine—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	3.79e-05	0.000272	CcSEcCtD
Mesalazine—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	3.78e-05	0.000272	CcSEcCtD
Mesalazine—Hypertension—Prednisone—systemic lupus erythematosus	3.78e-05	0.000272	CcSEcCtD
Mesalazine—Chills—Methotrexate—systemic lupus erythematosus	3.77e-05	0.000271	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	3.74e-05	0.000269	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	3.74e-05	0.000269	CcSEcCtD
Mesalazine—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	3.73e-05	0.000268	CcSEcCtD
Mesalazine—Myalgia—Prednisone—systemic lupus erythematosus	3.73e-05	0.000268	CcSEcCtD
Mesalazine—Arthralgia—Prednisone—systemic lupus erythematosus	3.73e-05	0.000268	CcSEcCtD
Mesalazine—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	3.72e-05	0.000268	CcSEcCtD
Mesalazine—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	3.72e-05	0.000267	CcSEcCtD
Mesalazine—Anxiety—Prednisone—systemic lupus erythematosus	3.71e-05	0.000267	CcSEcCtD
Mesalazine—Alopecia—Methotrexate—systemic lupus erythematosus	3.71e-05	0.000267	CcSEcCtD
Mesalazine—Insomnia—Dexamethasone—systemic lupus erythematosus	3.71e-05	0.000267	CcSEcCtD
Mesalazine—Insomnia—Betamethasone—systemic lupus erythematosus	3.71e-05	0.000267	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	3.7e-05	0.000266	CcSEcCtD
Mesalazine—Diarrhoea—Cyclosporine—systemic lupus erythematosus	3.69e-05	0.000266	CcSEcCtD
Mesalazine—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	3.69e-05	0.000265	CcSEcCtD
Mesalazine—Paraesthesia—Dexamethasone—systemic lupus erythematosus	3.68e-05	0.000265	CcSEcCtD
Mesalazine—Paraesthesia—Betamethasone—systemic lupus erythematosus	3.68e-05	0.000265	CcSEcCtD
Mesalazine—Discomfort—Prednisone—systemic lupus erythematosus	3.68e-05	0.000265	CcSEcCtD
Mesalazine—Mental disorder—Methotrexate—systemic lupus erythematosus	3.68e-05	0.000265	CcSEcCtD
Mesalazine—Erythema—Methotrexate—systemic lupus erythematosus	3.66e-05	0.000263	CcSEcCtD
Mesalazine—Hypersensitivity—Prednisolone—systemic lupus erythematosus	3.62e-05	0.000261	CcSEcCtD
Mesalazine—Dyspepsia—Dexamethasone—systemic lupus erythematosus	3.61e-05	0.00026	CcSEcCtD
Mesalazine—Dyspepsia—Betamethasone—systemic lupus erythematosus	3.61e-05	0.00026	CcSEcCtD
Mesalazine—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	3.6e-05	0.000259	CcSEcCtD
Mesalazine—Urticaria—Triamcinolone—systemic lupus erythematosus	3.59e-05	0.000258	CcSEcCtD
Mesalazine—Urticaria—Methylprednisolone—systemic lupus erythematosus	3.58e-05	0.000258	CcSEcCtD
Mesalazine—Dysgeusia—Methotrexate—systemic lupus erythematosus	3.58e-05	0.000258	CcSEcCtD
Mesalazine—Body temperature increased—Triamcinolone—systemic lupus erythematosus	3.57e-05	0.000257	CcSEcCtD
Mesalazine—Dizziness—Cyclosporine—systemic lupus erythematosus	3.57e-05	0.000257	CcSEcCtD
Mesalazine—Oedema—Prednisone—systemic lupus erythematosus	3.57e-05	0.000257	CcSEcCtD
Mesalazine—Anaphylactic shock—Prednisone—systemic lupus erythematosus	3.57e-05	0.000257	CcSEcCtD
Mesalazine—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	3.56e-05	0.000257	CcSEcCtD
Mesalazine—Decreased appetite—Dexamethasone—systemic lupus erythematosus	3.56e-05	0.000257	CcSEcCtD
Mesalazine—Decreased appetite—Betamethasone—systemic lupus erythematosus	3.56e-05	0.000257	CcSEcCtD
Mesalazine—Infection—Prednisone—systemic lupus erythematosus	3.55e-05	0.000255	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	3.54e-05	0.000255	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	3.54e-05	0.000255	CcSEcCtD
Mesalazine—Back pain—Methotrexate—systemic lupus erythematosus	3.54e-05	0.000255	CcSEcCtD
Mesalazine—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	3.54e-05	0.000254	CcSEcCtD
Mesalazine—Fatigue—Betamethasone—systemic lupus erythematosus	3.54e-05	0.000254	CcSEcCtD
Mesalazine—Fatigue—Dexamethasone—systemic lupus erythematosus	3.54e-05	0.000254	CcSEcCtD
Mesalazine—Shock—Prednisone—systemic lupus erythematosus	3.51e-05	0.000253	CcSEcCtD
Mesalazine—Pain—Dexamethasone—systemic lupus erythematosus	3.51e-05	0.000252	CcSEcCtD
Mesalazine—Pain—Betamethasone—systemic lupus erythematosus	3.51e-05	0.000252	CcSEcCtD
Mesalazine—Nervous system disorder—Prednisone—systemic lupus erythematosus	3.5e-05	0.000252	CcSEcCtD
Mesalazine—Tachycardia—Prednisone—systemic lupus erythematosus	3.49e-05	0.000251	CcSEcCtD
Mesalazine—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	3.48e-05	0.000251	CcSEcCtD
Mesalazine—Skin disorder—Prednisone—systemic lupus erythematosus	3.47e-05	0.00025	CcSEcCtD
Mesalazine—Hyperhidrosis—Prednisone—systemic lupus erythematosus	3.45e-05	0.000248	CcSEcCtD
Mesalazine—Vision blurred—Methotrexate—systemic lupus erythematosus	3.45e-05	0.000248	CcSEcCtD
Mesalazine—Asthenia—Hydrocortisone—systemic lupus erythematosus	3.44e-05	0.000248	CcSEcCtD
Mesalazine—Vomiting—Cyclosporine—systemic lupus erythematosus	3.43e-05	0.000247	CcSEcCtD
Mesalazine—Rash—Cyclosporine—systemic lupus erythematosus	3.41e-05	0.000245	CcSEcCtD
Mesalazine—Anorexia—Prednisone—systemic lupus erythematosus	3.4e-05	0.000245	CcSEcCtD
Mesalazine—Dermatitis—Cyclosporine—systemic lupus erythematosus	3.4e-05	0.000245	CcSEcCtD
Mesalazine—Pruritus—Hydrocortisone—systemic lupus erythematosus	3.4e-05	0.000244	CcSEcCtD
Mesalazine—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	3.39e-05	0.000244	CcSEcCtD
Mesalazine—Headache—Cyclosporine—systemic lupus erythematosus	3.38e-05	0.000243	CcSEcCtD
Mesalazine—Anaemia—Methotrexate—systemic lupus erythematosus	3.38e-05	0.000243	CcSEcCtD
Mesalazine—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	3.38e-05	0.000243	CcSEcCtD
Mesalazine—Feeling abnormal—Betamethasone—systemic lupus erythematosus	3.38e-05	0.000243	CcSEcCtD
Mesalazine—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	3.35e-05	0.000241	CcSEcCtD
Mesalazine—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	3.35e-05	0.000241	CcSEcCtD
Mesalazine—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	3.35e-05	0.000241	CcSEcCtD
Mesalazine—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	3.33e-05	0.00024	CcSEcCtD
Mesalazine—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	3.32e-05	0.000239	CcSEcCtD
Mesalazine—Rash—Mycophenolate mofetil—systemic lupus erythematosus	3.32e-05	0.000239	CcSEcCtD
Mesalazine—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	3.32e-05	0.000239	CcSEcCtD
Mesalazine—Headache—Mycophenolate mofetil—systemic lupus erythematosus	3.3e-05	0.000238	CcSEcCtD
Mesalazine—Malaise—Methotrexate—systemic lupus erythematosus	3.3e-05	0.000237	CcSEcCtD
Mesalazine—Vertigo—Methotrexate—systemic lupus erythematosus	3.29e-05	0.000236	CcSEcCtD
Mesalazine—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	3.28e-05	0.000236	CcSEcCtD
Mesalazine—Leukopenia—Methotrexate—systemic lupus erythematosus	3.27e-05	0.000236	CcSEcCtD
Mesalazine—Urticaria—Betamethasone—systemic lupus erythematosus	3.26e-05	0.000234	CcSEcCtD
Mesalazine—Urticaria—Dexamethasone—systemic lupus erythematosus	3.26e-05	0.000234	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	3.25e-05	0.000234	CcSEcCtD
Mesalazine—Dizziness—Prednisolone—systemic lupus erythematosus	3.25e-05	0.000234	CcSEcCtD
Mesalazine—Asthenia—Triamcinolone—systemic lupus erythematosus	3.24e-05	0.000233	CcSEcCtD
Mesalazine—Abdominal pain—Betamethasone—systemic lupus erythematosus	3.24e-05	0.000233	CcSEcCtD
Mesalazine—Abdominal pain—Dexamethasone—systemic lupus erythematosus	3.24e-05	0.000233	CcSEcCtD
Mesalazine—Body temperature increased—Betamethasone—systemic lupus erythematosus	3.24e-05	0.000233	CcSEcCtD
Mesalazine—Body temperature increased—Dexamethasone—systemic lupus erythematosus	3.24e-05	0.000233	CcSEcCtD
Mesalazine—Asthenia—Methylprednisolone—systemic lupus erythematosus	3.24e-05	0.000233	CcSEcCtD
Mesalazine—Insomnia—Prednisone—systemic lupus erythematosus	3.23e-05	0.000232	CcSEcCtD
Mesalazine—Nausea—Cyclosporine—systemic lupus erythematosus	3.21e-05	0.000231	CcSEcCtD
Mesalazine—Paraesthesia—Prednisone—systemic lupus erythematosus	3.21e-05	0.000231	CcSEcCtD
Mesalazine—Pruritus—Triamcinolone—systemic lupus erythematosus	3.2e-05	0.00023	CcSEcCtD
Mesalazine—Cough—Methotrexate—systemic lupus erythematosus	3.19e-05	0.00023	CcSEcCtD
Mesalazine—Pruritus—Methylprednisolone—systemic lupus erythematosus	3.19e-05	0.00023	CcSEcCtD
Mesalazine—Dizziness—Hydrocortisone—systemic lupus erythematosus	3.17e-05	0.000228	CcSEcCtD
Mesalazine—Dyspepsia—Prednisone—systemic lupus erythematosus	3.14e-05	0.000226	CcSEcCtD
Mesalazine—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	3.13e-05	0.000225	CcSEcCtD
Mesalazine—Chest pain—Methotrexate—systemic lupus erythematosus	3.11e-05	0.000224	CcSEcCtD
Mesalazine—Myalgia—Methotrexate—systemic lupus erythematosus	3.11e-05	0.000224	CcSEcCtD
Mesalazine—Arthralgia—Methotrexate—systemic lupus erythematosus	3.11e-05	0.000224	CcSEcCtD
Mesalazine—Decreased appetite—Prednisone—systemic lupus erythematosus	3.1e-05	0.000223	CcSEcCtD
Mesalazine—Rash—Prednisolone—systemic lupus erythematosus	3.1e-05	0.000223	CcSEcCtD
Mesalazine—Dermatitis—Prednisolone—systemic lupus erythematosus	3.1e-05	0.000223	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	3.09e-05	0.000222	CcSEcCtD
Mesalazine—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	3.09e-05	0.000222	CcSEcCtD
Mesalazine—Fatigue—Prednisone—systemic lupus erythematosus	3.08e-05	0.000222	CcSEcCtD
Mesalazine—Headache—Prednisolone—systemic lupus erythematosus	3.08e-05	0.000222	CcSEcCtD
Mesalazine—Discomfort—Methotrexate—systemic lupus erythematosus	3.08e-05	0.000221	CcSEcCtD
Mesalazine—Constipation—Prednisone—systemic lupus erythematosus	3.05e-05	0.00022	CcSEcCtD
Mesalazine—Vomiting—Hydrocortisone—systemic lupus erythematosus	3.05e-05	0.00022	CcSEcCtD
Mesalazine—Rash—Hydrocortisone—systemic lupus erythematosus	3.03e-05	0.000218	CcSEcCtD
Mesalazine—Dermatitis—Hydrocortisone—systemic lupus erythematosus	3.02e-05	0.000218	CcSEcCtD
Mesalazine—Confusional state—Methotrexate—systemic lupus erythematosus	3.01e-05	0.000217	CcSEcCtD
Mesalazine—Headache—Hydrocortisone—systemic lupus erythematosus	3.01e-05	0.000216	CcSEcCtD
Mesalazine—Dizziness—Triamcinolone—systemic lupus erythematosus	2.99e-05	0.000215	CcSEcCtD
Mesalazine—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	2.98e-05	0.000215	CcSEcCtD
Mesalazine—Dizziness—Methylprednisolone—systemic lupus erythematosus	2.98e-05	0.000215	CcSEcCtD
Mesalazine—Infection—Methotrexate—systemic lupus erythematosus	2.96e-05	0.000213	CcSEcCtD
Mesalazine—Feeling abnormal—Prednisone—systemic lupus erythematosus	2.94e-05	0.000212	CcSEcCtD
Mesalazine—Asthenia—Dexamethasone—systemic lupus erythematosus	2.94e-05	0.000212	CcSEcCtD
Mesalazine—Asthenia—Betamethasone—systemic lupus erythematosus	2.94e-05	0.000212	CcSEcCtD
Mesalazine—Nervous system disorder—Methotrexate—systemic lupus erythematosus	2.93e-05	0.000211	CcSEcCtD
Mesalazine—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	2.92e-05	0.00021	CcSEcCtD
Mesalazine—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	2.92e-05	0.00021	CcSEcCtD
Mesalazine—Nausea—Prednisolone—systemic lupus erythematosus	2.92e-05	0.00021	CcSEcCtD
Mesalazine—Pruritus—Dexamethasone—systemic lupus erythematosus	2.9e-05	0.000209	CcSEcCtD
Mesalazine—Pruritus—Betamethasone—systemic lupus erythematosus	2.9e-05	0.000209	CcSEcCtD
Mesalazine—Skin disorder—Methotrexate—systemic lupus erythematosus	2.9e-05	0.000209	CcSEcCtD
Mesalazine—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	2.89e-05	0.000208	CcSEcCtD
Mesalazine—Vomiting—Triamcinolone—systemic lupus erythematosus	2.87e-05	0.000207	CcSEcCtD
Mesalazine—Vomiting—Methylprednisolone—systemic lupus erythematosus	2.87e-05	0.000206	CcSEcCtD
Mesalazine—Nausea—Hydrocortisone—systemic lupus erythematosus	2.85e-05	0.000205	CcSEcCtD
Mesalazine—Rash—Triamcinolone—systemic lupus erythematosus	2.85e-05	0.000205	CcSEcCtD
Mesalazine—Dermatitis—Triamcinolone—systemic lupus erythematosus	2.85e-05	0.000205	CcSEcCtD
Mesalazine—Anorexia—Methotrexate—systemic lupus erythematosus	2.84e-05	0.000205	CcSEcCtD
Mesalazine—Rash—Methylprednisolone—systemic lupus erythematosus	2.84e-05	0.000205	CcSEcCtD
Mesalazine—Dermatitis—Methylprednisolone—systemic lupus erythematosus	2.84e-05	0.000204	CcSEcCtD
Mesalazine—Urticaria—Prednisone—systemic lupus erythematosus	2.84e-05	0.000204	CcSEcCtD
Mesalazine—Headache—Triamcinolone—systemic lupus erythematosus	2.83e-05	0.000204	CcSEcCtD
Mesalazine—Headache—Methylprednisolone—systemic lupus erythematosus	2.82e-05	0.000203	CcSEcCtD
Mesalazine—Abdominal pain—Prednisone—systemic lupus erythematosus	2.82e-05	0.000203	CcSEcCtD
Mesalazine—Body temperature increased—Prednisone—systemic lupus erythematosus	2.82e-05	0.000203	CcSEcCtD
Mesalazine—Diarrhoea—Dexamethasone—systemic lupus erythematosus	2.81e-05	0.000202	CcSEcCtD
Mesalazine—Diarrhoea—Betamethasone—systemic lupus erythematosus	2.81e-05	0.000202	CcSEcCtD
Mesalazine—Hypotension—Methotrexate—systemic lupus erythematosus	2.79e-05	0.000201	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	2.72e-05	0.000196	CcSEcCtD
Mesalazine—Dizziness—Betamethasone—systemic lupus erythematosus	2.71e-05	0.000195	CcSEcCtD
Mesalazine—Dizziness—Dexamethasone—systemic lupus erythematosus	2.71e-05	0.000195	CcSEcCtD
Mesalazine—Insomnia—Methotrexate—systemic lupus erythematosus	2.7e-05	0.000194	CcSEcCtD
Mesalazine—Nausea—Triamcinolone—systemic lupus erythematosus	2.68e-05	0.000193	CcSEcCtD
Mesalazine—Paraesthesia—Methotrexate—systemic lupus erythematosus	2.68e-05	0.000193	CcSEcCtD
Mesalazine—Nausea—Methylprednisolone—systemic lupus erythematosus	2.68e-05	0.000193	CcSEcCtD
Mesalazine—Dyspnoea—Methotrexate—systemic lupus erythematosus	2.66e-05	0.000191	CcSEcCtD
Mesalazine—Somnolence—Methotrexate—systemic lupus erythematosus	2.65e-05	0.000191	CcSEcCtD
Mesalazine—Hypersensitivity—Prednisone—systemic lupus erythematosus	2.63e-05	0.000189	CcSEcCtD
Mesalazine—Dyspepsia—Methotrexate—systemic lupus erythematosus	2.63e-05	0.000189	CcSEcCtD
Mesalazine—Vomiting—Betamethasone—systemic lupus erythematosus	2.61e-05	0.000188	CcSEcCtD
Mesalazine—Vomiting—Dexamethasone—systemic lupus erythematosus	2.61e-05	0.000188	CcSEcCtD
Mesalazine—Decreased appetite—Methotrexate—systemic lupus erythematosus	2.59e-05	0.000187	CcSEcCtD
Mesalazine—Rash—Dexamethasone—systemic lupus erythematosus	2.59e-05	0.000186	CcSEcCtD
Mesalazine—Rash—Betamethasone—systemic lupus erythematosus	2.59e-05	0.000186	CcSEcCtD
Mesalazine—Dermatitis—Betamethasone—systemic lupus erythematosus	2.58e-05	0.000186	CcSEcCtD
Mesalazine—Dermatitis—Dexamethasone—systemic lupus erythematosus	2.58e-05	0.000186	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	2.58e-05	0.000185	CcSEcCtD
Mesalazine—Fatigue—Methotrexate—systemic lupus erythematosus	2.57e-05	0.000185	CcSEcCtD
Mesalazine—Headache—Dexamethasone—systemic lupus erythematosus	2.57e-05	0.000185	CcSEcCtD
Mesalazine—Headache—Betamethasone—systemic lupus erythematosus	2.57e-05	0.000185	CcSEcCtD
Mesalazine—Asthenia—Prednisone—systemic lupus erythematosus	2.56e-05	0.000184	CcSEcCtD
Mesalazine—Pain—Methotrexate—systemic lupus erythematosus	2.55e-05	0.000184	CcSEcCtD
Mesalazine—Pruritus—Prednisone—systemic lupus erythematosus	2.53e-05	0.000182	CcSEcCtD
Mesalazine—Feeling abnormal—Methotrexate—systemic lupus erythematosus	2.46e-05	0.000177	CcSEcCtD
Mesalazine—Diarrhoea—Prednisone—systemic lupus erythematosus	2.44e-05	0.000176	CcSEcCtD
Mesalazine—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	2.44e-05	0.000176	CcSEcCtD
Mesalazine—Nausea—Dexamethasone—systemic lupus erythematosus	2.44e-05	0.000175	CcSEcCtD
Mesalazine—Nausea—Betamethasone—systemic lupus erythematosus	2.44e-05	0.000175	CcSEcCtD
Mesalazine—Urticaria—Methotrexate—systemic lupus erythematosus	2.37e-05	0.000171	CcSEcCtD
Mesalazine—Dizziness—Prednisone—systemic lupus erythematosus	2.36e-05	0.00017	CcSEcCtD
Mesalazine—Abdominal pain—Methotrexate—systemic lupus erythematosus	2.36e-05	0.00017	CcSEcCtD
Mesalazine—Body temperature increased—Methotrexate—systemic lupus erythematosus	2.36e-05	0.00017	CcSEcCtD
Mesalazine—Vomiting—Prednisone—systemic lupus erythematosus	2.27e-05	0.000163	CcSEcCtD
Mesalazine—Rash—Prednisone—systemic lupus erythematosus	2.25e-05	0.000162	CcSEcCtD
Mesalazine—Dermatitis—Prednisone—systemic lupus erythematosus	2.25e-05	0.000162	CcSEcCtD
Mesalazine—Headache—Prednisone—systemic lupus erythematosus	2.24e-05	0.000161	CcSEcCtD
Mesalazine—Hypersensitivity—Methotrexate—systemic lupus erythematosus	2.2e-05	0.000158	CcSEcCtD
Mesalazine—Asthenia—Methotrexate—systemic lupus erythematosus	2.14e-05	0.000154	CcSEcCtD
Mesalazine—Nausea—Prednisone—systemic lupus erythematosus	2.12e-05	0.000153	CcSEcCtD
Mesalazine—Pruritus—Methotrexate—systemic lupus erythematosus	2.11e-05	0.000152	CcSEcCtD
Mesalazine—Diarrhoea—Methotrexate—systemic lupus erythematosus	2.04e-05	0.000147	CcSEcCtD
Mesalazine—Dizziness—Methotrexate—systemic lupus erythematosus	1.97e-05	0.000142	CcSEcCtD
Mesalazine—Vomiting—Methotrexate—systemic lupus erythematosus	1.9e-05	0.000137	CcSEcCtD
Mesalazine—Rash—Methotrexate—systemic lupus erythematosus	1.88e-05	0.000135	CcSEcCtD
Mesalazine—Dermatitis—Methotrexate—systemic lupus erythematosus	1.88e-05	0.000135	CcSEcCtD
Mesalazine—Headache—Methotrexate—systemic lupus erythematosus	1.87e-05	0.000135	CcSEcCtD
Mesalazine—Nausea—Methotrexate—systemic lupus erythematosus	1.77e-05	0.000128	CcSEcCtD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL2—systemic lupus erythematosus	1.56e-05	0.000128	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—IL6—systemic lupus erythematosus	1.56e-05	0.000128	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CRP—systemic lupus erythematosus	1.56e-05	0.000128	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—IL6—systemic lupus erythematosus	1.56e-05	0.000127	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—TNFAIP3—systemic lupus erythematosus	1.55e-05	0.000127	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—BLK—systemic lupus erythematosus	1.54e-05	0.000126	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	1.52e-05	0.000124	CbGpPWpGaD
Mesalazine—CHUK—Immune System—PTPRC—systemic lupus erythematosus	1.51e-05	0.000124	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.51e-05	0.000124	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL1RN—systemic lupus erythematosus	1.51e-05	0.000123	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—TLR4—systemic lupus erythematosus	1.49e-05	0.000122	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TNF—systemic lupus erythematosus	1.49e-05	0.000122	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—C3—systemic lupus erythematosus	1.48e-05	0.000122	CbGpPWpGaD
Mesalazine—PTGS2—Disease—XRCC6—systemic lupus erythematosus	1.48e-05	0.000121	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—JUNB—systemic lupus erythematosus	1.48e-05	0.000121	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—IL6—systemic lupus erythematosus	1.46e-05	0.00012	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—IL6—systemic lupus erythematosus	1.46e-05	0.00012	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—systemic lupus erythematosus	1.46e-05	0.00012	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—IL6—systemic lupus erythematosus	1.45e-05	0.000119	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—CDKN1A—systemic lupus erythematosus	1.45e-05	0.000119	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—IL6—systemic lupus erythematosus	1.44e-05	0.000118	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—HLA-DRB1—systemic lupus erythematosus	1.43e-05	0.000117	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—IL6—systemic lupus erythematosus	1.43e-05	0.000117	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—C3—systemic lupus erythematosus	1.42e-05	0.000117	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.42e-05	0.000116	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TLR9—systemic lupus erythematosus	1.41e-05	0.000116	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CRP—systemic lupus erythematosus	1.41e-05	0.000116	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—IL6—systemic lupus erythematosus	1.41e-05	0.000115	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD40—systemic lupus erythematosus	1.41e-05	0.000115	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TYK2—systemic lupus erythematosus	1.4e-05	0.000115	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CTLA4—systemic lupus erythematosus	1.39e-05	0.000114	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HMGB1—systemic lupus erythematosus	1.39e-05	0.000114	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CD80—systemic lupus erythematosus	1.38e-05	0.000113	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—PTPRC—systemic lupus erythematosus	1.37e-05	0.000112	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—P2RY12—systemic lupus erythematosus	1.37e-05	0.000112	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL1RN—systemic lupus erythematosus	1.37e-05	0.000112	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IFNA1—systemic lupus erythematosus	1.36e-05	0.000112	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—TLR4—systemic lupus erythematosus	1.35e-05	0.000111	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—systemic lupus erythematosus	1.33e-05	0.000109	CbGpPWpGaD
Mesalazine—CHUK—Immune System—RASGRP1—systemic lupus erythematosus	1.33e-05	0.000109	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD79A—systemic lupus erythematosus	1.32e-05	0.000108	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CD80—systemic lupus erythematosus	1.32e-05	0.000108	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.31e-05	0.000107	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—HLA-DRB1—systemic lupus erythematosus	1.3e-05	0.000106	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—RXRA—systemic lupus erythematosus	1.3e-05	0.000106	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—systemic lupus erythematosus	1.3e-05	0.000106	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	1.29e-05	0.000106	CbGpPWpGaD
Mesalazine—CHUK—Disease—JUNB—systemic lupus erythematosus	1.29e-05	0.000106	CbGpPWpGaD
Mesalazine—CHUK—Immune System—PRL—systemic lupus erythematosus	1.29e-05	0.000105	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.29e-05	0.000105	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TLR9—systemic lupus erythematosus	1.28e-05	0.000105	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD40—systemic lupus erythematosus	1.28e-05	0.000105	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—NAT2—systemic lupus erythematosus	1.26e-05	0.000103	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.26e-05	0.000103	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CSK—systemic lupus erythematosus	1.26e-05	0.000103	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CTLA4—systemic lupus erythematosus	1.26e-05	0.000103	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HMGB1—systemic lupus erythematosus	1.26e-05	0.000103	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CD80—systemic lupus erythematosus	1.25e-05	0.000102	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.25e-05	0.000102	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—P2RY12—systemic lupus erythematosus	1.24e-05	0.000102	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IFNA1—systemic lupus erythematosus	1.24e-05	0.000101	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HLA-DQA1—systemic lupus erythematosus	1.22e-05	0.0001	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—RASGRP1—systemic lupus erythematosus	1.2e-05	9.86e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD79A—systemic lupus erythematosus	1.2e-05	9.83e-05	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CD80—systemic lupus erythematosus	1.2e-05	9.83e-05	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—IL6—systemic lupus erythematosus	1.2e-05	9.83e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—PRL—systemic lupus erythematosus	1.19e-05	9.74e-05	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.18e-05	9.67e-05	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—VDR—systemic lupus erythematosus	1.17e-05	9.62e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	1.17e-05	9.59e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—PRL—systemic lupus erythematosus	1.17e-05	9.56e-05	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—TYK2—systemic lupus erythematosus	1.16e-05	9.53e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NCF2—systemic lupus erythematosus	1.15e-05	9.43e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—LYN—systemic lupus erythematosus	1.14e-05	9.37e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HLA-DQB1—systemic lupus erythematosus	1.14e-05	9.36e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CSK—systemic lupus erythematosus	1.14e-05	9.35e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.12e-05	9.21e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.12e-05	9.19e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HLA-DQA1—systemic lupus erythematosus	1.11e-05	9.07e-05	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—MMP9—systemic lupus erythematosus	1.1e-05	9.05e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—HIST2H2AC—systemic lupus erythematosus	1.09e-05	8.95e-05	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.08e-05	8.87e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL18—systemic lupus erythematosus	1.08e-05	8.87e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD40LG—systemic lupus erythematosus	1.08e-05	8.84e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD8A—systemic lupus erythematosus	1.07e-05	8.74e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CSK—systemic lupus erythematosus	1.06e-05	8.72e-05	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—NR3C1—systemic lupus erythematosus	1.06e-05	8.66e-05	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—TYK2—systemic lupus erythematosus	1.05e-05	8.64e-05	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CD4—systemic lupus erythematosus	1.05e-05	8.62e-05	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—EP300—systemic lupus erythematosus	1.05e-05	8.58e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NCF2—systemic lupus erythematosus	1.04e-05	8.55e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—LYN—systemic lupus erythematosus	1.04e-05	8.49e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HLA-DQB1—systemic lupus erythematosus	1.04e-05	8.49e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—JAK1—systemic lupus erythematosus	1.03e-05	8.43e-05	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—PPARG—systemic lupus erythematosus	1.03e-05	8.43e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.02e-05	8.33e-05	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL6—systemic lupus erythematosus	1.01e-05	8.31e-05	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.01e-05	8.28e-05	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CD4—systemic lupus erythematosus	1.01e-05	8.27e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—RXRA—systemic lupus erythematosus	1.01e-05	8.26e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1e-05	8.2e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CD247—systemic lupus erythematosus	1e-05	8.2e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—NAT2—systemic lupus erythematosus	1e-05	8.2e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—IL6—systemic lupus erythematosus	9.97e-06	8.17e-05	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—VEGFA—systemic lupus erythematosus	9.92e-06	8.13e-05	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CDKN1B—systemic lupus erythematosus	9.89e-06	8.1e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL18—systemic lupus erythematosus	9.82e-06	8.04e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD40LG—systemic lupus erythematosus	9.78e-06	8.01e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—NCF2—systemic lupus erythematosus	9.73e-06	7.98e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD8A—systemic lupus erythematosus	9.67e-06	7.92e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL2RA—systemic lupus erythematosus	9.61e-06	7.88e-05	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CD4—systemic lupus erythematosus	9.53e-06	7.81e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—C3—systemic lupus erythematosus	9.53e-06	7.81e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—JAK1—systemic lupus erythematosus	9.5e-06	7.79e-05	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CDKN1B—systemic lupus erythematosus	9.49e-06	7.78e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	9.35e-06	7.66e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—JAK1—systemic lupus erythematosus	9.33e-06	7.65e-05	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—ALB—systemic lupus erythematosus	9.25e-06	7.58e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CXCL12—systemic lupus erythematosus	9.2e-06	7.54e-05	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL6—systemic lupus erythematosus	9.2e-06	7.54e-05	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CD4—systemic lupus erythematosus	9.16e-06	7.5e-05	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CDKN1A—systemic lupus erythematosus	9.12e-06	7.48e-05	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TGFB1—systemic lupus erythematosus	9.1e-06	7.46e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CRP—systemic lupus erythematosus	9.07e-06	7.43e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—IL6—systemic lupus erythematosus	9.04e-06	7.41e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—JUNB—systemic lupus erythematosus	9.03e-06	7.4e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—CCR5—systemic lupus erythematosus	9e-06	7.38e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	9e-06	7.38e-05	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CDKN1B—systemic lupus erythematosus	8.96e-06	7.35e-05	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—NOS3—systemic lupus erythematosus	8.84e-06	7.25e-05	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CDKN1A—systemic lupus erythematosus	8.76e-06	7.18e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL2RA—systemic lupus erythematosus	8.72e-06	7.14e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—TLR4—systemic lupus erythematosus	8.69e-06	7.12e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HLA-DRB1—systemic lupus erythematosus	8.68e-06	7.12e-05	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—EP300—systemic lupus erythematosus	8.68e-06	7.11e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—C3—systemic lupus erythematosus	8.64e-06	7.08e-05	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CDKN1B—systemic lupus erythematosus	8.61e-06	7.05e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—RASGRP1—systemic lupus erythematosus	8.58e-06	7.03e-05	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TNF—systemic lupus erythematosus	8.5e-06	6.96e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CXCL12—systemic lupus erythematosus	8.34e-06	6.84e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PRL—systemic lupus erythematosus	8.32e-06	6.82e-05	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CDKN1A—systemic lupus erythematosus	8.27e-06	6.78e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CRP—systemic lupus erythematosus	8.22e-06	6.74e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—JUNB—systemic lupus erythematosus	8.19e-06	6.71e-05	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—PTGS2—systemic lupus erythematosus	8.09e-06	6.63e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD80—systemic lupus erythematosus	8.02e-06	6.57e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	7.95e-06	6.51e-05	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CDKN1A—systemic lupus erythematosus	7.94e-06	6.51e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—TLR4—systemic lupus erythematosus	7.88e-06	6.46e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	7.88e-06	6.45e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HLA-DRB1—systemic lupus erythematosus	7.87e-06	6.45e-05	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—EP300—systemic lupus erythematosus	7.87e-06	6.45e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—RASGRP1—systemic lupus erythematosus	7.78e-06	6.38e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—JUNB—systemic lupus erythematosus	7.64e-06	6.26e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PRL—systemic lupus erythematosus	7.54e-06	6.18e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—CD80—systemic lupus erythematosus	7.41e-06	6.07e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD80—systemic lupus erythematosus	7.27e-06	5.96e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	7.15e-06	5.86e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—RXRA—systemic lupus erythematosus	7.06e-06	5.79e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—PRL—systemic lupus erythematosus	7.04e-06	5.77e-05	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—IL6—systemic lupus erythematosus	6.86e-06	5.62e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—TYK2—systemic lupus erythematosus	6.77e-06	5.55e-05	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—EP300—systemic lupus erythematosus	6.73e-06	5.51e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—JAK1—systemic lupus erythematosus	6.65e-06	5.45e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	6.55e-06	5.37e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IFNG—systemic lupus erythematosus	6.34e-06	5.2e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCR5—systemic lupus erythematosus	6.31e-06	5.17e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—TYK2—systemic lupus erythematosus	6.25e-06	5.12e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL2RA—systemic lupus erythematosus	6.21e-06	5.09e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—C3—systemic lupus erythematosus	6.16e-06	5.05e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—TYK2—systemic lupus erythematosus	6.14e-06	5.03e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—NOS3—systemic lupus erythematosus	6.14e-06	5.03e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD4—systemic lupus erythematosus	6.12e-06	5.02e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—JAK1—systemic lupus erythematosus	6.03e-06	4.94e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CDKN1B—systemic lupus erythematosus	5.76e-06	4.72e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IFNG—systemic lupus erythematosus	5.75e-06	4.71e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ALB—systemic lupus erythematosus	5.72e-06	4.69e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCR5—systemic lupus erythematosus	5.72e-06	4.69e-05	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—IL6—systemic lupus erythematosus	5.69e-06	4.66e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—CD4—systemic lupus erythematosus	5.65e-06	4.63e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.64e-06	4.62e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL2—systemic lupus erythematosus	5.64e-06	4.62e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—JAK1—systemic lupus erythematosus	5.63e-06	4.61e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—PTGS2—systemic lupus erythematosus	5.61e-06	4.6e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—RXRA—systemic lupus erythematosus	5.61e-06	4.59e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—C3—systemic lupus erythematosus	5.59e-06	4.58e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD4—systemic lupus erythematosus	5.55e-06	4.55e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—NOS3—systemic lupus erythematosus	5.47e-06	4.49e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—F2—systemic lupus erythematosus	5.41e-06	4.43e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CCR5—systemic lupus erythematosus	5.33e-06	4.37e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—CDKN1B—systemic lupus erythematosus	5.32e-06	4.36e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CDKN1A—systemic lupus erythematosus	5.31e-06	4.35e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CDKN1B—systemic lupus erythematosus	5.22e-06	4.28e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.2e-06	4.26e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CD80—systemic lupus erythematosus	5.19e-06	4.25e-05	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—IL6—systemic lupus erythematosus	5.16e-06	4.23e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL2—systemic lupus erythematosus	5.11e-06	4.19e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—EP300—systemic lupus erythematosus	5.06e-06	4.14e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PTGS2—systemic lupus erythematosus	5.01e-06	4.1e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—CDKN1A—systemic lupus erythematosus	4.91e-06	4.02e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—F2—systemic lupus erythematosus	4.91e-06	4.02e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCL2—systemic lupus erythematosus	4.82e-06	3.95e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CDKN1A—systemic lupus erythematosus	4.82e-06	3.95e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CD80—systemic lupus erythematosus	4.7e-06	3.85e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—EP300—systemic lupus erythematosus	4.67e-06	3.83e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—EP300—systemic lupus erythematosus	4.59e-06	3.76e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PPARG—systemic lupus erythematosus	4.46e-06	3.65e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CD80—systemic lupus erythematosus	4.39e-06	3.6e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TYK2—systemic lupus erythematosus	4.38e-06	3.59e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCL2—systemic lupus erythematosus	4.37e-06	3.58e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NOS3—systemic lupus erythematosus	4.3e-06	3.52e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—EP300—systemic lupus erythematosus	4.16e-06	3.41e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—TGFB1—systemic lupus erythematosus	4.06e-06	3.33e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ALB—systemic lupus erythematosus	4.01e-06	3.29e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TYK2—systemic lupus erythematosus	3.97e-06	3.25e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NOS3—systemic lupus erythematosus	3.9e-06	3.19e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—NOS3—systemic lupus erythematosus	3.84e-06	3.14e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.72e-06	3.05e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—TYK2—systemic lupus erythematosus	3.7e-06	3.03e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL2—systemic lupus erythematosus	3.64e-06	2.99e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—NOS3—systemic lupus erythematosus	3.64e-06	2.98e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PPARG—systemic lupus erythematosus	3.54e-06	2.9e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PTGS2—systemic lupus erythematosus	3.51e-06	2.87e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MMP9—systemic lupus erythematosus	3.45e-06	2.83e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.44e-06	2.82e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.38e-06	2.77e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CD4—systemic lupus erythematosus	3.35e-06	2.74e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL6—systemic lupus erythematosus	3.31e-06	2.71e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL2—systemic lupus erythematosus	3.3e-06	2.71e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—EP300—systemic lupus erythematosus	3.27e-06	2.68e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ALB—systemic lupus erythematosus	3.18e-06	2.61e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CDKN1B—systemic lupus erythematosus	3.15e-06	2.58e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MMP9—systemic lupus erythematosus	3.13e-06	2.56e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.12e-06	2.55e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.1e-06	2.54e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—IL6—systemic lupus erythematosus	3.06e-06	2.51e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—NOS3—systemic lupus erythematosus	3.04e-06	2.49e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL6—systemic lupus erythematosus	3e-06	2.46e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—EP300—systemic lupus erythematosus	2.96e-06	2.43e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—EP300—systemic lupus erythematosus	2.92e-06	2.39e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CDKN1A—systemic lupus erythematosus	2.91e-06	2.38e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.84e-06	2.33e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.81e-06	2.3e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—EP300—systemic lupus erythematosus	2.77e-06	2.27e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.58e-06	2.11e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—TGFB1—systemic lupus erythematosus	2.4e-06	1.97e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—EP300—systemic lupus erythematosus	2.32e-06	1.9e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL6—systemic lupus erythematosus	2.14e-06	1.75e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL6—systemic lupus erythematosus	1.94e-06	1.59e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—IL6—systemic lupus erythematosus	1.81e-06	1.48e-05	CbGpPWpGaD
